"Promising Results: CAR-T Cell Therapy Shrinks Brain Tumors in Early Trials"
TL;DR
A clinical trial for CAR-T cell therapy in patients with glioblastoma, a deadly form of brain cancer, has shown promising results, with some patients experiencing significant tumor regression just days after treatment. The therapy, which uses a patient's own immune cells to target the tumor, resulted in near-complete tumor regression in one patient after five days. The researchers emphasize the need for further research to refine this treatment, but are optimistic about its potential to change the outlook for this challenging disease.
Topics:healthmedical-breakthrough#brain-cancer#car-t-cell-therapy#clinical-trial#glioblastoma#medical-breakthrough#tumor-regression
- CAR-T Cell Therapy Achieves Near-Complete Tumor Regression in Brain Cancer After Five Days Good News Network
- ‘Nothing else that has had this effect’: New treatment shrinks brain tumors in small clinical trial at Mass. General The Boston Globe
- Early clinical trial results show 'dramatic and rapid' regression of glioblastoma after next generation CAR-T therapy Medical Xpress
- Living drugs that reprogram patients’ immune cells show early promise against hard-to-treat brain tumors CNN
- In two early trials, blood cancer treatment appears promising for deadly brain tumor NBC News
Want the full story? Read the original reporting
Read on Good News Network